Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.74B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.61B |
| 3 |
Microsoft
MSFT
|
+$1.16B |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.02B |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$834M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.58B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.54B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.5B |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$639M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$552M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.13% |
| 2 | Financials | 8.44% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Healthcare | 7.43% |
| 5 | Industrials | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Concentrix
CNXC
$1.61B
| $16.6M | ﹤0.01% |
168,808
-63,874
| -27% | -$5.56M |
|
2077
PUT
General Dynamics
GD
$105B
| $16.6M | ﹤0.01% |
63,800
+59,400
| +1,350% | +$14.5M |
|
2078
Innoviva
INVA
$1.53B
| $16.5M | ﹤0.01% |
1,031,631
+13,781
| +1% | +$193K |
|
2079
4D Molecular Therapeutics
FDMT
$552M
| $16.5M | ﹤0.01% |
816,343
+658,069
| +416% | +$8.66M |
|
|
VBTX
2080
DELISTED
Veritex Holdings
VBTX
| $16.5M | ﹤0.01% |
710,737
-102,401
| -13% | -$2.02M |
|
2081
Applied Optoelectronics
AAOI
$9.97B
| $16.5M | ﹤0.01% |
853,948
+825,223
| +2,873% | +$10.8M |
|
2082
DigitalOcean
DOCN
$14.4B
| $16.5M | ﹤0.01% |
449,294
-248,796
| -36% | -$6.88M |
|
|
PPLI
2083
People Inc
PPLI
$3.2B
| $16.5M | ﹤0.01% |
383,502
-147,805
| -28% | -$5.79M |
|
2084
Eagle Materials
EXP
$6.48B
| $16.4M | ﹤0.01% |
80,972
-5,832
| -7% | -$1.03M |
|
2085
Symbotic
SYM
$5.14B
| $16.4M | ﹤0.01% |
319,698
+275,494
| +623% | +$12.1M |
|
2086
Sabre
SABR
$886M
| $16.4M | ﹤0.01% |
3,727,334
+1,761,499
| +90% | +$6.8M |
|
2087
Lithia Motors
LAD
$8.26B
| $16.4M | ﹤0.01% |
49,797
+4,818
| +11% | +$1.32M |
|
2088
Axsome Therapeutics
AXSM
$10.8B
| $16.4M | ﹤0.01% |
205,815
+46,566
| +29% | +$3.11M |
|
2089
CALL
Illumina
ILMN
$29.3B
| $16.4M | ﹤0.01% |
120,790
-31,765
| -21% | -$3.66M |
|
2090
Haemonetics
HAE
$3.87B
| $16.4M | ﹤0.01% |
191,253
+24,394
| +15% | +$2.11M |
|
2091
CALL
XPeng
XPEV
$11.2B
| $16.4M | ﹤0.01% |
1,120,900
+870,900
| +348% | +$13.8M |
|
2092
Gold Fields
GFI
$33.4B
| $16.3M | ﹤0.01% |
1,129,278
+669,819
| +146% | +$9.26M |
|
2093
Immatics
IMTX
$1.29B
| $16.3M | ﹤0.01% |
1,548,909
+1,183,860
| +324% | +$10.9M |
|
2094
Stevanato
STVN
$5.54B
| $16.3M | ﹤0.01% |
597,606
-112,235
| -16% | -$3.23M |
|
2095
DraftKings
DKNG
$11B
| $16.2M | ﹤0.01% |
459,981
-105,478
| -19% | -$3.53M |
|
2096
Blue Owl Capital
OBDC
$5.58B
| $16.2M | ﹤0.01% |
1,098,035
+887,904
| +423% | +$12.6M |
|
2097
Lesaka Technologies
LSAK
$403M
| $16.2M | ﹤0.01% |
4,997,335
| – | – |
|
|
LTHM
2098
DELISTED
Livent Corporation
LTHM
| $16.2M | ﹤0.01% |
899,981
-108,597
| -11% | -$1.69M |
|
2099
Sabra Healthcare REIT
SBRA
$5.34B
| $16.2M | ﹤0.01% |
1,132,518
-85,644
| -7% | -$1.22M |
|
2100
Murphy USA
MUSA
$9.9B
| $16.1M | ﹤0.01% |
45,273
-48,972
| -52% | -$17.7M |
|
Similar funds
Goldman Sachs's Q4 2023 Portfolio in Review
As of Q4 2023, Goldman Sachs held 6,018 positions worth $543B, up 15% from $470B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Goldman Sachs deployed $17.8B of net new capital in Q4 2023, opening 537 new positions and adding to 2,390 existing holdings. Its largest new stake was Goldman Sachs MarketBeta Russell 1000 Value Equity ETF: 9,747,656 shares worth $415M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $1.58B trimmed.
- Goldman Sachs's largest Q4 2023 buy was Goldman Sachs MarketBeta Russell 1000 Value Equity ETF: 9,747,656 shares worth $415M.
- Goldman Sachs added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $2.74B increase.
- Goldman Sachs's biggest Q4 2023 reduction was Apple, cutting an estimated $1.58B.
- Goldman Sachs fully exited Activision Blizzard in Q4 2023, selling an estimated $639M.
- Goldman Sachs's ten largest holdings make up 18% of its $543B portfolio in Q4 2023.
- Goldman Sachs opened 537 new positions and closed 416 in Q4 2023.
- Goldman Sachs's portfolio value rose 15% quarter-over-quarter to $543B.
Based on Goldman Sachs's 13F filing for Q4 2023, filed 13 Feb 2024.